Andrew Paul Feinberg

Andrew Paul Feinberg
Andrew Paul Feinberg
Born	August 5, 1952
Alma mater	Johns Hopkins University;
Known for	cancer epigenetics
	Scientific career
Institutions	Johns Hopkins University; University of Michigan;

Andrew Paul Feinberg (born August 5, 1952) is the director of the Center for Epigenetics, chief of the Division of Molecular Medicine in the Department of Medicine, and the King Fahd Professor of Medicine, Oncology, Molecular Biology & Genetics in the School of Medicine at Johns Hopkins University.[1]

Andrew Feinberg received his B.A. in 1973 and M.D. in 1976 from the accelerated medical program at Johns Hopkins University, as well as an M.P.H. from Johns Hopkins in 1981. He did his residency in internal medicine, followed by a fellowship in genetics at Hopkins. He did a postdoctoral fellowship in developmental biology at UCSD where he researched the multiple differentiation paths of Dictyostelium discoideum. His research into hereditary inheritance of traits outside of DNA was initially seen as controversial, and he was told that if he continued this work, his funding would be cut off.[2]

Dr. Feinberg discovered epigenetic alterations in human cancer with Bert Vogelstein in 1983. He is also credited with the discovery of gene imprinting in humans.[1] He has made many contributions to the field of epigenetics in cancer, and discovered the molecular basis of Beckwith-Wiedemann syndrome.[2] He pursued this work while he was an HHMI Investigator at the University of Michigan from 1986-1994,[3] when he returned to Johns Hopkins as King Fahd Professor of Molecular Medicine in the Department of Medicine.

Awards

Elected Fellow of the American Academy of Arts and Sciences, 2009[1]
Elected Fellow of the American Association for the Advancement of Science, 2011
Elected Member of the Institute of Medicine of the National Academy of Sciences, 2007
ISI, Most Cited Authors List (Top 0.1%), 2001
MERIT Award, National Cancer Institute, 2001
Delta Omega, National Public Health Honorary Society, 1981
Wallenberg Fellow, Royal Swedish Academy of Sciences, 2009
American Society for Clinical Investigation, 1990
Association of American Physicians, 1995
Feodor Lynen Medal, 2011
NIH Director's Pioneer Award, 2011

References

http://www.hopkinsmedicine.org/profiles/results/directory/profile/5351655/andrew-feinberg-1%5B%5D
Feinberg, Andrew (2009). "Interview: Professor Andrew Feinberg speaks to Epigenomics". Epigenomics. 1 (1): 25–7. doi:10.2217/epi.09.8. PMID 22122634.
Feinberg, Andrew (2014). "DNA methylation in cancer: Three decades of discovery". Genome Medicine. 6 (5): 36. doi:10.1186/gm553. PMC 4062051. PMID 25031622.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[hopkinsmedicine_profile-1] ttp://www.hopkinsmedicine.org/profiles/results/directory/profile/5351655/andrew-feinberg-1%5B%5D

[pmid22122634-2] Feinberg, Andrew (2009). "Interview: Professor Andrew Feinberg speaks to Epigenomics". Epigenomics. 1 (1): 25–7. doi:10.2217/epi.09.8. PMID 22122634.

[3] Feinberg, Andrew (2014). "DNA methylation in cancer: Three decades of discovery". Genome Medicine. 6 (5): 36. doi:10.1186/gm553. PMC 4062051. PMID 25031622.